Baby care equipment mainly includes: baby warmer, baby jaundice meter, baby tester and so on. With the decline in the birth rate in recent years, the baby care equipment business is actually difficult to get effective expansion, more of a stock market update iteration. At present, the original baby care equipment on the market is basically 7~8 years to replace a batch.
This business can bring Davy Medicals a relatively stable cash flow, but can not support the future development of the enterprise.
Because the wholly owned subsidiary of Davy Medicals, Velcade, has developed a new generation of luminal anastomosis, especially the electric luminal anastomosis is able to replace the original traditional foreign products.
According to research organizations, in the next five years, the global anastomosis will become a tens of billions of dollars in the market, the domestic market will reach 19 billion yuan. The domestic market will also reach 19 billion RMB. Among them, the electric luminal anastomosis will occupy 15% of the market, i.e., about 3 billion RMB.
According to the optimistic forecast, if Verkedi can occupy 25% of the domestic market, then the annual sales of about 750 million yuan, contributing to net profit of about 200 million yuan.
According to the length of 3 years projection, after 3 years, the baby care box can provide about 100 million net profit, electric anastomosis can provide 200 million net profit, add up to a **** 300 million net profit.
According to the medical device equipment 30 times the price-earnings ratio estimate, the enterprise market value will be 9 billion yuan.
But this is also a more idealized state, in fact, there are many uncertainties exist, such as the influx of other domestic manufacturers (seems to be a lack of technical barriers), there are already a number of companies have developed similar products, including Lanshan Medical, Yingtukang, wind and medical, Yisi medical, may lead to a rapid decline in the profitability of the electric luminal anastomosis, the market occupancy rate is also declining.
In addition, with the further deepening of medical equipment procurement, the future of electric lumenscope anastomosis is expected to face the risk of procurement, at that time, the entire market will face a reshuffle. The profit of the product will be a substantial decline.
According to the original forecast, the domestic electric luminal anastomosis in 24 years sales will reach 700,000 units, if David Medical can get 20% of the market, then it will sell 140,000 units, according to the set of procurement of each electric luminal anastomosis 1,000 yuan of profit estimates, then the gross profit can only reach 140 million yuan, far lower than the original estimate.
So the future growth space of Davy Medicals is mainly determined by the sales of Velcade's luminal anastomosis, to pay close attention to the information in this regard.